Diabetic Nephropathy Type 2
29
5
6
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
1 terminated out of 29 trials
90.0%
+3.5% vs benchmark
14%
4 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (29)
Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
Atrasentan in Patients With Proteinuric Glomerular Diseases
Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients
Relationship of Serum Zinc Level with Severity of Diabetic Nephropathy
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Investigational and Comparative Study in the Management of Diabetic Nephropathy
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient